These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 17360743)
1. The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. Bell I; Martin A; Roberts S J Virol; 2007 Jun; 81(11):5437-48. PubMed ID: 17360743 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2. Prescott EL; Brimacombe CL; Hartley M; Bell I; Graham S; Roberts S J Virol; 2014 Nov; 88(21):12599-611. PubMed ID: 25142587 [TBL] [Abstract][Full Text] [Related]
3. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium. Bryan JT; Han A; Fife KH; Brown DR Virology; 2000 Mar; 268(2):430-9. PubMed ID: 10704351 [TBL] [Abstract][Full Text] [Related]
4. Cooperation between different forms of the human papillomavirus type 1 E4 protein to block cell cycle progression and cellular DNA synthesis. Knight GL; Grainger JR; Gallimore PH; Roberts S J Virol; 2004 Dec; 78(24):13920-33. PubMed ID: 15564500 [TBL] [Abstract][Full Text] [Related]
5. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins. Knight GL; Turnell AS; Roberts S J Virol; 2006 Aug; 80(15):7416-26. PubMed ID: 16840322 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Roberts S; Ashmole I; Johnson GD; Kreider JW; Gallimore PH Virology; 1993 Nov; 197(1):176-87. PubMed ID: 8212552 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) - splicing factor axis. Mole S; Faizo AAA; Hernandez-Lopez H; Griffiths M; Stevenson A; Roberts S; Graham SV J Gen Virol; 2020 May; 101(5):523-532. PubMed ID: 32182205 [TBL] [Abstract][Full Text] [Related]
8. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry. Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847 [TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes. Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216 [TBL] [Abstract][Full Text] [Related]
10. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts. Roberts S; Hillman ML; Knight GL; Gallimore PH J Virol; 2003 Jan; 77(1):673-84. PubMed ID: 12477870 [TBL] [Abstract][Full Text] [Related]
12. Identification of an arginine-rich motif in human papillomavirus type 1 E1;E4 protein necessary for E4-mediated inhibition of cellular DNA synthesis in vitro and in cells. Roberts S; Kingsbury SR; Stoeber K; Knight GL; Gallimore PH; Williams GH J Virol; 2008 Sep; 82(18):9056-64. PubMed ID: 18632869 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the arginine/serine repeats of lamin B receptor by SRPK1-insights from molecular dynamics simulations. Sellis D; Drosou V; Vlachakis D; Voukkalis N; Giannakouros T; Vlassi M Biochim Biophys Acta; 2012 Jan; 1820(1):44-55. PubMed ID: 22056509 [TBL] [Abstract][Full Text] [Related]
14. The pathobiology and mechanisms of infection of HPV. Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J; Feller L SADJ; 2010 Apr; 65(3):124-6. PubMed ID: 20496845 [TBL] [Abstract][Full Text] [Related]
15. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720 [TBL] [Abstract][Full Text] [Related]
16. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. Firzlaff JM; Galloway DA; Eisenman RN; Lüscher B New Biol; 1989 Oct; 1(1):44-53. PubMed ID: 2562189 [TBL] [Abstract][Full Text] [Related]
17. The human papillomavirus 16 E2 protein is stabilised in S phase. Johansson C; Graham SV; Dornan ES; Morgan IM Virology; 2009 Nov; 394(2):194-9. PubMed ID: 19781729 [TBL] [Abstract][Full Text] [Related]
18. Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein. Zheng Y; Fu XD; Ou JH Virology; 2005 Nov; 342(1):150-8. PubMed ID: 16122776 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Mistry N; Simonsson M; Evander M Virol J; 2007 Mar; 4():27. PubMed ID: 17352804 [TBL] [Abstract][Full Text] [Related]
20. Interaction between human papillomavirus type 5 E2 and polo-like kinase 1. Wang WS; Lee MS; Tseng CE; Liao IH; Huang SP; Lin RI; Li C J Med Virol; 2009 Mar; 81(3):536-44. PubMed ID: 19152411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]